These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36975174)

  • 1. The effects of LactoCare synbiotic administration on chemotherapy-induced nausea, vomiting, diarrhea, and constipation in children with ALL: A double-blind randomized clinical trial.
    Eghbali A; Ghaffari K; Khalilpour A; Afzal RR; Eghbali A; Ghasemi A
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30328. PubMed ID: 36975174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Lactocare® Synbiotic Administration on the Serum Electrolytes and Trace Elements Levels in Psoriasis Patients: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial Study.
    Akbarzadeh A; Taheri M; Ebrahimi B; Alirezaei P; Doosti-Irani A; Soleimani M; Nouri F
    Biol Trace Elem Res; 2022 Oct; 200(10):4230-4237. PubMed ID: 34845600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do synbiotics really enhance beneficial synbiotics effect on defecation symptoms in healthy adults?: Randomized, double-blind, placebo-controlled trial.
    Ito D; Yamamoto Y; Maekita T; Yamagishi N; Kawashima S; Yoshikawa T; Tanioka K; Yoshida T; Iguchi M; Kunitatsu K; Kanai Y; Kato S; Kitano M
    Medicine (Baltimore); 2022 Feb; 101(8):e28858. PubMed ID: 35212286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic in Patients with Functional Diarrhea and High Fecal Calprotectin Levels: A Pilot Study.
    Jung S; Kim KM; Youn SM; Kim KN
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the efficacy of synbiotics in the treatment of functional constipation in children: a randomized double-blind placebo-controlled study.
    Baştürk A; Artan R; Atalay A; Yılmaz A
    Turk J Gastroenterol; 2017 Sep; 28(5):388-393. PubMed ID: 28705786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron versus granisetron in the prevention of chemotherapy induced nausea and vomiting in children with acute lymphoblastic leukemia.
    Siddique R; Hafiz MG; Rokeya B; Jamal CY; Islam A
    Mymensingh Med J; 2011 Oct; 20(4):680-8. PubMed ID: 22081189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of nutritional treatment and synbiotic use on gastrointestinal symptoms reduction in HIV-infected patients: Randomized clinical trial.
    Santos ASEAC; Silveira EAD; Falco MO; Nery MW; Turchi MD
    Clin Nutr; 2017 Jun; 36(3):680-685. PubMed ID: 27395330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral compound probiotic supplements can improve the quality of life for patients with lung cancer during chemotherapy: A randomized placebo-controlled study.
    Wei H; Yue Z; Han J; Chen P; Xie K; Sun Y; Zhu J
    Thorac Cancer; 2024 Jan; 15(2):182-191. PubMed ID: 38018652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK).
    Joss RA; Bacchi M; Buser K; Kirchner V; Neuenschwander H; Orth B; Aapro MS; Thürlimann B
    Ann Oncol; 1994 Mar; 5(3):253-8. PubMed ID: 8186174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a new synbiotic supplement on symptoms, stool consistency, intestinal transit time and gut microbiota in patients with severe functional constipation: a pilot randomized double-blind, controlled trial.
    Bazzocchi G; Giovannini T; Giussani C; Brigidi P; Turroni S
    Tech Coloproctol; 2014 Oct; 18(10):945-53. PubMed ID: 25091346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of Postchemotherapy Complications With the Use of Probiotics in Children With Acute Lymphoblastic Leukemia.
    Reyna-Figueroa J; Bejarano-Juvera AA; García-Parra C; Barrón-Calvillo EE; Queipo-Garcia GE; Galindo-Delgado P
    J Pediatr Hematol Oncol; 2021 May; 43(4):e457-e461. PubMed ID: 33031162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study.
    Kovács G; Wachtel AE; Basharova EV; Spinelli T; Nicolas P; Kabickova E
    Lancet Oncol; 2016 Mar; 17(3):332-344. PubMed ID: 26795844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: a double-blind, placebo-controlled, comparative study.
    Goedhals L; Heron JF; Kleisbauer JP; Pagani O; Sessa C
    Ann Oncol; 1998 Jun; 9(6):661-6. PubMed ID: 9681082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: A randomized controlled trial.
    Baştürk A; Artan R; Yılmaz A
    Turk J Gastroenterol; 2016 Sep; 27(5):439-443. PubMed ID: 27782892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron Delayed Emesis Study Group.
    Olver I; Paska W; Depierre A; Seitz JF; Stewart DJ; Goedhals L; McQuade B; McRae J; Wilkinson JR
    Ann Oncol; 1996 Nov; 7(9):945-52. PubMed ID: 9006746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial.
    Schwartzberg LS; Modiano MR; Rapoport BL; Chasen MR; Gridelli C; Urban L; Poma A; Arora S; Navari RM; Schnadig ID
    Lancet Oncol; 2015 Sep; 16(9):1071-1078. PubMed ID: 26272768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of synbiotics supplementation on reducing chemotherapy-induced side effects in women with breast cancer: a randomized placebo-controlled double-blind clinical trial.
    Khazaei Y; Basi A; Fernandez ML; Foudazi H; Bagherzadeh R; Shidfar F
    BMC Complement Med Ther; 2023 Sep; 23(1):339. PubMed ID: 37752516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study.
    Mizutani Y; Kawamoto S; Takahashi M; Doi H; Wakida K; Tabuchi S; Tanda M; Soga A; Chijiki R; Takakura H; Kawaguchi K; Higashime A; Watanabe M; Ichikawa H; Matsumoto S; Sakai R; Goto H; Kurata K; Kakiuchi S; Miyata Y; Uryu K; Inui Y; Kitao A; Yakushijin K; Matsuoka H; Minami H
    Intern Med; 2023 Oct; 62(20):2949-2958. PubMed ID: 36792187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly or moderately emetogenic chemotherapy: a randomized, double-blind, placebo-controlled study.
    Mizukami N; Yamauchi M; Koike K; Watanabe A; Ichihara K; Masumori N; Yamakage M
    J Pain Symptom Manage; 2014 Mar; 47(3):542-50. PubMed ID: 23856100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.